TREA

98214461 - PRL

Follow

Information

  • Trademark
  • 98214461
  • Serial Number
    98214461
  • Filing Date
    October 09, 2023
    a year ago
  • Transaction Date
    December 31, 2024
    a month ago
  • Status Date
    December 31, 2024
    a month ago
  • Published for Opposition Date
    December 31, 2024
    a month ago
  • Location Date
    December 09, 2024
    a month ago
  • Status Code
    686
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    PEISECKI, MARK
  • Attorney Docket Number
    39957/3542PR
    Attorney Name
    Jonathan M. Gelchinsky
    Law Office Assigned Location Code
    L50
  • Owners
Information
Mark Drawing Code
4
Mark Identification
PRL
Case File Statements
  • GS0051: Lipids, lipid nanoparticles, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and small molecule compounds for medical use; pharmaceutical preparations and therapeutic agents, namely, for RNA, gene therapy and mRNA regulation; pharmaceutical and biological preparations for medical use for the treatment of genetic and genomic disorders by gene therapy and mRNA regulation for use in human and animal therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; pharmaceutical preparations for gene therapy and mRNA regulation
  • GS0011: Chemical and biological agents for scientific and research use, namely, lipids, lipid nanoparticles, lipid formulations, nucleic acids and modified nucleic acids, namely, short RNAs and messenger RNAs; nucleic acid sequences for scientific purposes, research purposes, and laboratory purposes other than medical and veterinary purposes
  • GS0421: Research and development in the field of technology and engineering of lipids, lipid nanoparticles, lipid formulations and RNAs for use in gene therapy and mRNA regulation; development of new technology for others for enabling the engineering and modification of lipids, lipid nanoparticles, lipid formulations, RNAs, namely, developing molecular and cellular biology reagents, techniques, and assays for use in pharmaceutical and biomedical industry
Case File Event Statements
  • 10/15/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/12/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 4/26/2024 - 9 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/15/2024 - 6 months ago
    7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 7/15/2024 - 6 months ago
    8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 10/4/2024 - 4 months ago
    12 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/4/2024 - 4 months ago
    11 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/4/2024 - 4 months ago
    10 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 10/4/2024 - 4 months ago
    13 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/4/2024 - 4 months ago
    9 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/30/2024 - 3 months ago
    16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/30/2024 - 3 months ago
    15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/30/2024 - 3 months ago
    14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/1/2024 - 3 months ago
    17 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/4/2024 - 2 months ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/25/2024 - a month ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/31/2024 - a month ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/31/2024 - a month ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/30/2024 - 9 months ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/30/2024 - 9 months ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/30/2024 - 9 months ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT